Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. [electronic resource]
Producer: 20160623Description: 1845-52 p. digitalISSN:- 1523-6536
- Alefacept
- Anemia, Aplastic -- therapy
- Blood Component Transfusion -- statistics & numerical data
- Bone Marrow Transplantation
- CD2 Antigens -- immunology
- Child
- Cord Blood Stem Cell Transplantation
- Dyskeratosis Congenita -- therapy
- Fanconi Anemia -- therapy
- Female
- Graft Survival
- Graft vs Host Disease -- etiology
- Historically Controlled Study
- Humans
- Immunologic Memory
- Immunophenotyping
- Infant
- Killer Cells, Natural -- drug effects
- Lymphocyte Depletion -- methods
- Male
- Pilot Projects
- Recombinant Fusion Proteins -- supply & distribution
- T-Lymphocyte Subsets -- drug effects
- Transplantation Conditioning
- Unrelated Donors
No physical items for this record
Publication Type: Case Reports; Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.